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Abstract
Background: Electroporation is currently receiving much attention as a way to increase drug and
DNA delivery. Recent studies demonstrated the feasibility of electrogene therapy using a range of
therapeutic genes for the treatment of experimental tumors. However, the transfection efficiency
of electroporation-assisted DNA delivery is still low compared to viral methods and there is a clear
need to optimize this approach. In order to optimize treatment, knowledge about spatial and time
dependency of gene expression following delivery is of utmost importance in order to improve
gene delivery. Intravital microscopy of tumors growing in dorsal skin fold window chambers is a
useful method for monitoring gene transfection, since it allows non-invasive dynamic monitoring of
gene expression in tumors in a live animal.
Methods: Intravital microscopy was used to monitor real time spatial distribution of the green
fluorescent protein (GFP) and time dependence of transfection efficiency in syngeneic P22 rat
tumor model. DNA alone, liposome-DNA complexes and electroporation-assisted DNA delivery
using two different sets of electric pulse parameters were compared.
Results: Electroporation-assisted DNA delivery using 8 pulses, 600 V/cm, 5 ms, 1 Hz was superior
to other methods and resulted in 22% increase in fluorescence intensity in the tumors up to 6 days
post-transfection, compared to the non-transfected area in granulation tissue. Functional GFP was
detected within 5 h after transfection. Cells expressing GFP were detected throughout the tumor,
but not in the surrounding tissue that was not exposed to electric pulses.
Conclusions: Intravital microscopy was demonstrated to be a suitable method for monitoring
time and spatial distribution of gene expression in experimental tumors and provided evidence that
electroporation-assisted gene delivery using 8 pulses, 600 V/cm, 5 ms, 1 Hz is an effective method,
resulting in early onset and homogenous distribution of gene expression in the syngeneic P22 rat
tumor model.
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Despite some promising early results, gene therapy does
not, as yet, live up to expectation [1]. The main stumbling
block remains gene delivery, and all advances in the con-
trol of gene expression and selection of therapeutic genes
are hampered by inefficient gene transfection. Hence the
development of a safe and effective method of gene deliv-
ery in vivo is of utmost importance if gene therapy is to
move from the experimental to the clinical stage.
Electroporation is currently receiving much attention as a
way to increase drug and DNA delivery [2-5]. Electropora-
tion has long been used as an effective in vitro gene deliv-
ery system in both prokaryotes and eukaryotic cells.
Electroporation is a physical means of importing small
molecules and macromolecules into cells via increased
cell membrane permeability. Electroporation combined
with chemotherapeutic drugs bleomycin and cisplatin
(electrochemotherapy) has shown to be very promising
antitumor therapy. It was tested on many different tumor
types on the preclinical level demonstrating high antitu-
mor effectiveness resulting in tumor cures at very low
chemotherapeutic doses. It was also tested in clinical trials
for the treatment of accessible cutaneous tumors of differ-
ent histological types in cancer patients resulting in up to
100% objective responses [4,6,7]. Recent studies demon-
strated the feasibility of electrogene therapy using a range
of therapeutic genes for the treatment of experimental
tumors [4,8-14]. However, the transfection efficiency of
electroporation-assisted DNA delivery is still low com-
pared to viral methods and there is a clear need to opti-
mize this approach [5,14,15]. In studies designed to
determine transfection efficiency in tumors, tissue
homogenates, tissue sections or measurement of fluores-
cence in whole-tumor specimens using fluorescence stere-
omicroscope have been employed. Different plasmids
have also been used to analyze transfection efficiencies,
such as those encoding the green fluorescence protein
(GFP), β-galactosidase or luciferase [5,14,15], making
direct comparisons difficult.
In order to optimize treatment, knowledge about spatial
and time dependency of gene expression following deliv-
ery is of utmost importance in order to improve gene
delivery. This information is also important for the timing
of gene therapy with other cancer treatment modalities.
Intravital microscopy of tumors growing in dorsal skin
fold window chambers is a useful method for monitoring
gene transfection, since it allows non-invasive dynamic
monitoring of gene expression in tumors in a live animal
[16,17]. So far, only one study has used this technique to
monitor the activity of an adenovirus in infecting a mam-
mary cell carcinoma over the course of several days [16].
In the present study, we used intravital microscopy to
monitor real time spatial distribution of gene transfection
using the GFP reporter gene in rat P22 tumors. We fol-
lowed time dependency of transfection efficiency; com-
pared liposome-DNA complexes and electroporation
assisted DNA delivery using two different sets of electrical
parameters.
Methods
Animals and tumors
All animal experiments were carried out in accordance
with the UK animals (Scientific Procedures) Act 1986, fol-
lowing the UKCCCR guidelines and with approval from
the local Ethical Review Committee of the Gray Cancer
Institute.
Early generations of the P22 transplanted rat carcinosar-
coma were used in experiments. Donor tumors were
grown subcutaneously in the left flank of 8–10 week old
male BD9 rats [18].
Expression of GFP following electroporation-assisted gene deliv ry using EP1Figure 1
Expression of GFP following electroporation-assisted 
gene delivery using EP1 GFP expression was monitored 
in the rat P22 tumor growing in rat dorsal flap window cham-
ber following electroporation-assisted gene delivery using 
EP1 (8 electric pulses, 600 V/cm, 5 ms, 1 Hz). a. image taken 
under visible light condition on day 0 (x4 objective), b. image 
taken under fluorescence epi-illumination on day 0 before 
administration of DNA and electroporation (x4 objective), c. 
image taken under fluorescence epi-illumination on day 2 (x4 
objective); d. image taken under fluorescence epi-illumination 
on day 2 (x20 objective).
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Surgery was carried out under general anesthesia using
intraperitoneal injection of fluanisone (10 mg/kg), fenta-
nyl citrate (0.315 mg/kg) ('Hypnorm', Janssen Animal
Health, UK) and midazolam (2 mg/kg) ('Hypnovel',
Roche Products Ltd., UK) as described previously [18].
Briefly, animals were kept warm using heating pads
throughout the surgical procedure and aseptic technique
was used throughout. Window chambers, consisting of a
double-sided aluminum frame, holding two parallel glass
windows approximately 200 µm apart, were surgically
implanted into the dorsal skin of male BD9 rats, weighing
approximately 200 g. Surgery involved removal of the epi-
dermal and dermal layers of both skin layers of a dorsal
skin flap, except for the deepest fascia layer on each side,
and then securing the two sides of the chamber to the skin
using stainless steel screws and sutures. The two fascia lay-
ers moved freely between the two glass windows, follow-
ing these procedures. Early generation subcutaneous
transplants of the P22 rat carcinosarcoma were used as
donor tumors, when they reached approximately 0.5 cm
in diameter. A tumor fragment (~0.5 mm diameter) was
placed onto one of the fascia layers within the window
chamber on the day of surgery. Animals were given an
intraperitoneal injection of a few milliliters dextrose-
saline, immediately following surgery and kept on a
warmed pad until recovery from anesthesia. Subse-
quently, animals were kept in a warm room (30–34°C)
until the day of experiment. Three animals were used for
each experimental group.
Study design
Transfection was carried out 7 to 14 days following sur-
gery, when tumors measured 3–4 mm in diameter, using
a plasmid encoding the green fluorescent protein (GFP; p-
EGFP-N1, Clontech, Basingstoke, UK). Animals were
anaesthetized with Hypnorm and midazolam. The win-
dow on the tumor side was removed and 40 µg of DNA
alone or encapsulated in lipofectin (30 µl; Life Technolo-
gies, Paisley, UK) vesicles was carefully placed on the
tumor surface in a total volume of 75 µl in phosphate
buffered solution [5]. One minute thereafter, electropora-
tion was carried out by application of 8 square electric
pulses generated by an electroporator (built in-house).
Pulses were delivered by two flat, parallel stainless steel
electrodes (two stainless steel strips: length 15 mm, width
4 mm with rounded corners) 3 mm apart that were placed
at the diametrically opposed edges of the tumor. Two dif-
ferent electroporation protocols were used: EP1 – ampli-
tude 180 V (voltage/distance ratio 600 V/cm); pulse
length 5 ms; repetition frequency 1 Hz and EP2 – ampli-
tude 390 V (voltage/distance ratio 1300 V/cm); pulse
length 0.1 ms; repetition frequency 1 Hz. Immediately
after the procedure, the glass window was replaced and
GFP fluorescence monitored at selected time points for 6
days.
Intravital microscopy
Intravital microscopy was carried out using an inverted
Nikon Diaphot 200 fluorescence microscope, with a stage
modified in-house for holding rats. Animals were anaes-
thetized with Hypnorm and midazolam and placed on
the stage, in such a way that the window chamber was
located centrally above the objectives using location
screws. Rectal temperature was maintained between 34–
37°C throughout the experiment, using a thermostatically
controlled heating pad beneath the rat and an infrared
overhead lamp for maintenance of tumor temperature.
Tumor preparations were alternatively viewed at each
time point under transmitted visible light for measure-
ment of tumor diameter and under fluorescence epi-illu-
mination using a 100 W mercury arc lamp, for
visualization of GFP fluorescence (excitation filter of 450–
490 nm, emission filter of 520 nm) using x1.6, x4, x10
and x20 objective. Prior to transfection, two different
regions of interest (ROI) using x10 objective were
selected, one in the center of the tumor and one in the
tumor periphery. Tumor preparations were monitored at
Comparison of transfection efficiency between tumour center and periphery foll wing two different electroporation pro ocolFigure 2
Comparison of transfection efficiency between 
tumour center and periphery following two different 
electroporation protocols GFP expression in rat P22 
tumor growing in rat dorsal flap window chamber 2 days 
after two different electroporation conditions: EP1: 8 electric 
pulses, 600 V/cm, 5 ms, 1 Hz (a, c); EP2: 8 electric pulses, 
1300 V/cm, 0.1 ms, 1 Hz (b, d). Comparison of transfection 
efficiency in the ROI's of tumor center (a, b) and periphery 
(c, d) (x10 objective). Arrows: edge of the tumor.
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tion.
Data analysis
Observations were recorded in digital format, using a
Sony DSR-30P digital videocassette recorder, for off-line
analysis. Multiple frames (typically 10) were captured
onto computer and the images averaged for the analysis of
the fluorescence intensity using the Visilog Image Process-
ing package (Noesis, France). Increase in fluorescence
intensity in the tumors was determined by subtracting the
values of fluorescence intensity of non-transfected granu-
lation tissue from the values of tumors and normalizing
them to the values of non-transfected tissue. The calcula-
tions were performed for each animal at all time points.
Statistical analysis
Statistical analysis was carried out using SigmaStat Statis-
tical software (Systat Software GmbH, Erkrath, Germany).
Data were tested for normality using Kolmogorov-Smir-
nov test and differences between the groups were tested
for significance using Holm-Sidak method, after one-way
repeated measures analysis of variance was performed. A
value of p < 0.05 for the comparisons was considered to
represent a significant difference between groups.
Results and discussion
Three different types of non-viral transfection methods
were compared: DNA alone, liposome-DNA complex and
electroporation-assisted DNA delivery, using two different
sets of electric pulse parameters. Transfection of GFP was
monitored using intravital microscopy on syngeneic P22
rat carcinosarcoma tumors growing in the dorsal skin flap
window chamber of BD9 rats (Figure 1). The transfection
efficiency was evaluated by monitoring real time spatial
distribution and time dependence of GFP fluorescence.
Among the tested transfection methods, electroporation-
assisted gene delivery was the most effective method for
transfection of tumors growing in the window chamber.
Two different sets of electric pulse parameters were tested;
EP2 resulted in up to 17%, while EP1 in up to 22%
increase in fluorescence intensity in the tumors. EP2 has
previously been proven to be effective in electrochemo-
therapy of accessible cutaneous tumors in patients with
histologically different types of tumors [6,7], and also for
electrogenetherapy [8]. On the other hand, EP1 electric
pulses have already been shown to be effective for gene
delivery of solid tumors of different histology and origin
(rat, mouse and human) [5]. Transfection efficiency using
either DNA alone or liposome-DNA complex was lower
(7% and 12%, respectively) compared to electroporation-
assisted gene delivery.
Spatial distribution of transfected cells differed between
the two sets of electric pulses parameters. When using EP1
electric pulse parameters, cells expressing GFP were more
spread out through the whole tumor, compared to EP2
conditions, where cells expressing GFP were limited to the
areas that were close to the positioning of the electrodes
(Figure 2). Electroporation of the cell membrane is a phys-
ical phenomenon that occurs above a certain threshold of
induced transmembrane potential and is dependent on
electric pulse parameters such as pulse length, pulse
amplitude, number and pulses sequence [4]. According to
the current knowledge at a single cell level, DNA electro-
transfer is a process involving attachment of DNA to the
electropermeabilized side of the cell facing the cathode,
aggregation of DNA and its translocation to the cytoplas-
mic side of the cell [19]. Therefore, in the case of EP2, the
conditions suitable for DNA electro-transfer (above the
threshold level) in vivo appeared to be obtained only in
the vicinity of the electrodes, whereas in the case of EP1 a
larger area of the tumor was prone to DNA transfer. Effec-
tiveness of electroporation-assisted gene delivery was also
evident by lack of transfection efficiency in the granular
tissue surrounding the tumor that was not exposed to
electric pulses, but to DNA only (Figure 2). In addition,
more homogenous distribution of transfection efficiency
using EP1 conditions compared to EP2 conditions could
Time dependence of transfection efficiency comparing differ-ent transf r methodsF gu e 3
Time dependence of transfection efficiency compar-
ing different transfer methods DNA or liposome-DNA 
complexes were administered to the top of the tumor grow-
ing in window chamber. Electric pulses were applied to the 
tumor immediately after the addition of DNA. Two sets of 
electric pulse parameters were used: EP1 (8 electric pulses, 
600 V/cm, 5 ms, 1 Hz) and EP2 (8 electric pulses, 1300 V/cm, 
0.1 ms, 1 Hz). Average of three animals/group +/- standard 
error of the mean.Page 4 of 7
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duration of the EP1 pulses.
Functional GFP was formed within 5 h after transfection
regardless of the transfection method used (Figures 3, 4).
Detectable green fluorescence is the end result of a series
of events, including transfer of the DNA encoding GFP
into the cell, evasion of intracellular nucleases, transfer to
the nucleus, transcription and translation, and finally,
folding of the protein into a functional protein's fluoro-
phore. Topical administration of DNA to the tumors in
the window chamber (40 µg of DNA) resulted in very low
transfection efficiency, the increase in fluorescence inten-
sity in the tumors was up to 7% at day 2 post-transfection,
and remained at this level up to day 6. Administration of
liposome-DNA complexes resulted in increased transfec-
tion efficiency in the tumors compared to DNA alone (P =
0.032). The increase was up to 12% with the similar level
of GFP expression on day 6 post-transfection as after the
administration of DNA only (Figure 3). Similar results
were obtained in our previous study on dense cell suspen-
sions and solid subcutaneous P22 tumors where lipo-
some-DNA complexes resulted in significantly higher GFP
transfection efficiency compared to DNA injection only
[5]. These results are in accordance with several preclinical
and clinical studies demonstrating efficient gene-transfer
to solid tumors using liposome-DNA complexes [20,21].
The highest increase in fluorescence intensity was
obtained with electroporation-assisted gene delivery
using EP1 in the present study. The fluorescence intensity
increased to 22% at day 2 post-transfection and then
remained at this level over the observation period of 6
days. Electroporation assisted gene delivery with EP2 was
less effective than with EP1, although it was better than
liposome-DNA complex alone. These results are in
accordance with our previous study, where electropora-
Representative images of time related transfection efficiency of electroporation-assisted gene delivery using EP1 conditionsFigure 4
Representative images of time related transfection efficiency of electroporation-assisted gene delivery using 
EP1 conditions Example images taken under visible light condition (a) and under fluorescence epi-illumination (b) on day 0 
before administration of DNA and electroporation. Example images of transfection efficiency in tumors at 5 h (c), 2 (d), 4 (e) 
and 6 days post-transfection (f). (x10 objective).
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parameters yielded higher transfection efficiency com-
pared to lipofectin-enhanced method. The transfection
efficiencies that were obtained in the present study were
much higher compared to the transfection efficiency that
we obtained in our previous study on P22 solid tumors
growing subcutaneously in SCID mice [5]. The possible
reason for this is the absence of the skin overlying the
tumors in the window chamber. In subcutaneously grow-
ing tumors, the presence of the stratum corneum of the
skin causes the electric field intensity to drop substan-
tially, especially in the centre of the tumor, compared to
the electric field intensity in the skin [22,23]. The absence
of this effect in the window tumors may account for the
increased transfection efficiency observed in the current
study, as predicted from theoretical analyses [22,23].
It is worth noting that the fluorescence level remained
approximately constant throughout the observation
period for all transfection methods. This means that, as
the tumors grew during the 6-day observation period
(tumor diameter increased approximately 2-fold), plas-
mid DNA appeared to be present in the progeny cells. In
addition, intravital microscopy demonstrated that appli-
cation of electric pulses to the tumors did not induce
major cell damage as no effect on the tumor growth was
observed compared to untreated controls. Six days post
transfection there was no difference in increase in tumor
diameter between the tumors that were transfected with
DNA alone (2.2 fold), liposome-DNA complexes (2.3
fold), and electroporation-assisted DNA delivery using
EP1 (2.4 fold) or EP2 (2.2 fold).
Conclusions
In conclusion, this study showed that intravital micros-
copy is useful for monitoring the spatial and temporal
efficacy of electroporation methods for gene transfection
in animal tumor models. As such, it will be valuable for
the evaluation of new methods of optimizing gene deliv-
ery. Electroporation-assisted gene delivery using EP1 was
found to result in early onset and homogenous distribu-
tion of gene expression in the P22 tumor model. Further
improvement in transfection efficiency may be gained by
optimizing electric pulse parameters.
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